GENE ONLINE|News &
Opinion
Blog

2022-02-26| In-Depth

BIO CEO 2022: Trends and Opportunities in Biotechnology Investments

by GeneOnline
Share To
In the midst of the global pandemic, venture funding has continued to reach record-breaking levels. In light of this emerging trend in the investment in biotechnology, the 2022 BIO CEO & Investor Conference began with a panel discussion on the recent data on venture trends and therapeutic and platform areas of growth. Additional investors also provided their outlook of 2022, areas of concern with the public health landscape, and opportunities for the sector.

It's free! Log in now to read

LATEST
Neurodegenerative and Metabolic Disease Challenges and Solutions at ASGCT 2025
2025-05-15
Study: Aligning U.S. Drug Prices with Europe Could Reduce American Life Expectancy by Six Months
2025-05-15
Tribal Leaders Warn Senators: Federal Health Funding Cuts Threaten Native American Health.
2025-05-14
Health Secretary Kennedy Retracts Parts of Agency Reorganization Plan During Combative Congressional Hearing
2025-05-14
SURMOUNT-5 Trial: Zepbound Shows Greater Weight Loss Than Wegovy
2025-05-14
ASCGT Meeting Navigates Biotech Downturn After Multi-Year Slump
2025-05-14
Seasonal Skin Irritations Rise, Driving Demand for Accessible and Easy-to-Use Treatments
2025-05-14
EVENT
2025-05-13
ASGCT 28th Annual Meeting 2025
New Orleans, U.S.A.
2025-05-30
ASCO Annual Meeting 2025
Chicago, U.S.A
2025-06-11
ISSCR 2025 Annual Meeting
Hong Kong
2025-06-16
US BIO International Convention
Boston, U.S.A.
Scroll to Top